Moore Capital Management »

Relay Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.7M 414k 18.71
2020-12-31 $5.4M 130k 41.56

More positions owned by Moore Capital Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Applied Materials (AMAT)
Hut 8 Corp (HUT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Regal-beloit Corporation (RRX)
Devon Energy Corporation (DVN)
Apollo Global Mgmt (APO)
Lam Research Corp Com New (LRCX)
Citigroup Com New (C)
Bloom Energy Corp Com Cl A (BE)

View all positions for Moore Capital Management

Top funds holding Relay Therapeutics

Sb Investment Advisers
FMR
Casdin Capital
BlackRock
Perceptive Advisors
Commodore Capital
Vanguard Capital Management
Nextech Invest
State Street Corporation
Bellevue Group
Geode Capital Management
TCG Crossover Management
Alliancebernstein
Siren
Goldman Sachs Group

View all funds holding Relay Therapeutics